Article 5.
United Kingdom
In order to obtain one single consent covering several releases, all the necessary information for each release should be indicated in the single F1application, including sufficient information on the different sites of the releases and on the experimental design, as well as indication of any conditions for risk management for each different release. Clear reference to each release to be covered should be made in the application F2....
Annotations
Textual amendments
- F1
Word in Annex para. 5 substituted (31.12.2020) by The Genetically Modified Organisms (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/90), regs. 1(2)(b), 7(9)(a); 2020 c. 1, Sch. 5 para. 1(1)
- F2
Words in Annex para. 5 omitted (31.12.2020) by virtue of The Genetically Modified Organisms (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/90), regs. 1(2)(b), 7(9)(b); 2020 c. 1, Sch. 5 para. 1(1)